News
Oncovita secures US FDA orphan drug designation for its lead oncolytic virus candidate, MVdeltaC to treat pleural mesothelioma: Paris Saturday, June 7, 2025, 15:00 Hrs [IST] Oncov ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback